We are very pleased to announce the appointment of Mark Johnson as the new Director of Clinical Trial Services at Client Pharma CTS.
Mark’s considerable knowledge of the global pharmaceutical supply chain and experience within the industry furthers Client Pharma CTS’s ability to support manufacturers, sponsors, biotechs, CROs and patients alike.
He will be playing a key role, continuing Client Pharma’s mission, to improve the lives of people worldwide, ensuring that research & development organisations have access to the resources they need regardless of geographical, commercial or political boundaries.
